4.7 Article

Usability of serum inter-α-trypsin inhibitor heavy chain 4 as a biomarker for assessing severity and predicting functional outcome after human aneurysmal subarachnoid hemorrhage: A prospective observational cohort study at a single institution

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medical Laboratory Technology

Longitudinal change of serum inter-alpha-trypsin inhibitor heavy chain H4, and its correlation with inflammation, multiorgan injury, and death risk in sepsis

Xiangwang Zhao et al.

Summary: Serum ITIH4 is reduced in sepsis patients and correlated with inflammatory cytokines and disease severity. It gradually increases from disease onset to day 7 and reflects the reduction of systemic inflammation and 28-day mortality for sepsis.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2023)

Review Clinical Neurology

Early Brain Injury After Subarachnoid Hemorrhage: Incidence and Mechanisms

David C. Lauzier et al.

Summary: Aneurysmal subarachnoid hemorrhage is a devastating condition with significant morbidity and mortality. There is a need to identify therapeutic targets for this disease, particularly focusing on the early brain injury that develops in the first 72 hours after hemorrhage. Improved understanding of the mechanisms and biomarkers for early brain injury has led to the recognition of its increased clinical incidence and the need for further research in this area.

STROKE (2023)

Article Medicine, General & Internal

Longitudinal Change of Serum Inter-α-Trypsin Inhibitor Heavy Chain H4 and its Relation with Inflammation, Disease Recurrence, and Mortality in Acute Ischemic Stroke Patients

Jianli Zhang et al.

Summary: This study aimed to investigate the longitudinal change and prognostic role of ITIH4 in acute ischemic stroke. The results showed that ITIH4 levels were reduced in acute ischemic stroke patients compared to controls. ITIH4 was negatively associated with inflammatory cytokines and correlated with increased risk of stroke recurrence and mortality.

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2023)

Article Clinical Neurology

Elevated Serum NOX2 Levels Contribute to Delayed Cerebral Ischemia and a Poor Prognosis After Aneurysmal Subarachnoid Hemorrhage: A Cohort Study

Xiaoyu Wu et al.

Summary: In this study, serum levels of NADPH oxidase 2 (NOX2) were found to be highly expressed in injured brain tissues of patients with aneurysmal subarachnoid hemorrhage (aSAH). Serum NOX2 levels were correlated with disease severity, delayed cerebral ischemia (DCI), and prognosis after aSAH.

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2023)

Article Medicine, General & Internal

Serum inter-alpha-trypsin inhibitor heavy chain 4 in patients with inflammatory bowel disease: correlation with disease risk, inflammation, activity, and its variation after treatment

Nuan Wen et al.

Summary: ITIH4 plays vital roles in inflammatory and auto-immune diseases, and its expression correlates with disease activity and inflammation in IBD patients. The elevation of ITIH4 after treatment is associated with clinical response in IBD patients.

IRISH JOURNAL OF MEDICAL SCIENCE (2022)

Article Medical Laboratory Technology

Inter-alpha-trypsin inhibitor heavy chain 4: A serologic marker relating to disease risk, activity, and treatment outcomes of rheumatoid arthritis

Kejian He et al.

Summary: The study demonstrated that circulating ITIH4 levels were lower in RA patients compared to healthy controls, and were closely associated with inflammatory markers and disease activity. Furthermore, ITIH4 levels showed a gradual increase after treatment, and were linked to treatment response and remission.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2022)

Article Clinical Neurology

The management of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

B. Balanca et al.

Summary: Aneurysmal subarachnoid hemorrhage is a rare event with a high social impact on younger patients. The management of this condition involves addressing early brain injuries and preventing delayed cerebral ischemia, which is a significant cause of mortality and morbidity. The understanding of the pathophysiology and strategies for diagnosis, prevention, and treatment of delayed cerebral ischemia is evolving.

REVUE NEUROLOGIQUE (2022)

Article Clinical Neurology

The REACT study: design of a randomized phase 3 trial to assess the efficacy and safety of clazosentan for preventing deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

Nicolas Bruder et al.

Summary: The REACT study aims to evaluate the safety and efficacy of clazosentan in preventing clinical deterioration caused by delayed cerebral ischemia (DCI) in patients with aneurysmal subarachnoid hemorrhage (aSAH). The study will enroll 400 patients with aSAH and assess whether clazosentan reduces the risk of clinical deterioration due to DCI. The primary efficacy endpoint is the occurrence of clinical deterioration, with secondary endpoints including cerebral infarction, quality of life, and functional assessment at 12 weeks.

BMC NEUROLOGY (2022)

Article Medicine, Research & Experimental

Serum ITIH4 in coronary heart disease: a potential anti-inflammatory biomarker related to stenosis degree and risk of major adverse cardiovascular events

Yanfei Huo et al.

Summary: This study investigates the relationship between ITIH4 and inflammatory cytokines, stenosis degrees, and prognosis in coronary heart disease patients. The results show that serum ITIH4 levels are reduced in CHD patients and negatively correlated with inflammatory cytokines and stenosis degrees. High levels of ITIH4 are associated with a lower risk of major adverse cardiovascular events in CHD patients.

BIOMARKERS IN MEDICINE (2022)

Review Clinical Neurology

Aneurysmal Subarachnoid Hemorrhage: the Last Decade

Sean N. Neifert et al.

Summary: Aneurysmal subarachnoid hemorrhage (SAH) is a serious cerebrovascular disease with high mortality and morbidity rates, requiring early surgical intervention to repair the ruptured aneurysm. Patients should be treated in specialized neurologic intensive care units to prevent and manage complications.

TRANSLATIONAL STROKE RESEARCH (2021)

Review Neurosciences

Delayed Cerebral Ischemia after Subarachnoid Hemorrhage

Asad Ikram et al.

Summary: Delayed cerebral ischemia (DCI) is a major concern in patients with aSAH, and beyond large cerebral artery vasospasm, other factors such as microvascular spasm and thrombosis may contribute to its occurrence. Inflammation of brain parenchyma is believed to be the key factor leading to DCI, highlighting the need for improved diagnostic modalities and development of new interventions for prevention and treatment.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2021)

Article Biochemistry & Molecular Biology

ITIH4, as an inflammation biomarker, mainly increases in bacterial bloodstream infection

Yating Ma et al.

Summary: This study found that the expression level of ITIH4 significantly increased during bloodstream infection, especially in bacterial infection. IL-6 and LPS had a significant impact on the expression of ITIH4, while stimulation by TNF-alpha or IL-10 did not have a significant effect.

CYTOKINE (2021)

Article Neurosciences

Systemic Inflammation Response Index and Systemic Immune-inflammation Index for Predicting the Prognosis of Patients with Aneurysmal Subarachnoid Hemorrhage

Seonyong Yun et al.

Summary: This study found that SIRI and SII index values are associated with clinical outcomes in patients with aSAH. Elevated SIRI and SII index could be independent predicting factors for a poor prognosis after aSAH.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2021)

Article Clinical Neurology

Acute systematic inflammatory response syndrome and serum biomarkers predict outcomes after subarachnoid hemorrhage

Masaaki Hokari et al.

JOURNAL OF CLINICAL NEUROSCIENCE (2020)

Article Respiratory System

Inter--inhibitor Ameliorates Endothelial Inflammation in Sepsis

Vandy P. Stober et al.

Article Neurosciences

Acute Anti-Inflammatory Markers ITIH4 and AHSG in Mice Brain of a Novel Alzheimer's Disease Model

Xiaowen Shi et al.

JOURNAL OF ALZHEIMERS DISEASE (2019)

Review Clinical Neurology

Early Brain Injury After Poor-Grade Subarachnoid Hemorrhage

Verena Rass et al.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2019)

Article Multidisciplinary Sciences

Biomarkers for Severity of Spinal Cord Injury in the Cerebrospinal Fluid of Rats

Joanna M. Lubieniecka et al.

PLOS ONE (2011)

Article Medical Laboratory Technology

Inter-α-trypsin inhibitor heavy chain 4 is a novel marker of acute ischemic stroke

Rajpal S. Kashyap et al.

CLINICA CHIMICA ACTA (2009)

Review Cell Biology

Structure and Function of Inter--Trypsin Inhibitor Heavy Chains

Lisheng Zhuo et al.

CONNECTIVE TISSUE RESEARCH (2008)